Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
US biotech Aktis Oncology has filed IPO documents with the Securities and Exchange Commission (SEC), in what could be the first biotech listing on the Nasdaq in 2026. The Boston-based ...
While little is known about what the large-scale data center will be used for at this point, here’s a closer look at what we do know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results